Bausch + Lomb Corporation
$17.07
-$0.16 (-0.93%)
$17.01Day Range$17.34
Key Statistics
Market Cap
$6.15B
Shares Outstanding
357.2M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
May 6, 2022
Round Lot
100
Locale
US
Trading Data
Day Open
$17.22
Day High
$17.34
Day Low
$17.01
Volume
194.0K
VWAP
$17.12
Prev Close
$17.23
Transactions
--
Acc. Volume
--
About Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
OPHTHALMIC GOODSSIC 385113,000 employees520 APPLEWOOD CRESCENT, VAUGHAN, A6, L4K 4B4908-541-5456IPO May 6, 2022US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001860742
- Composite FIGI
- BBG014KG1L68
- Share Class FIGI
- BBG014KG1GY8
- Ticker Root
- BLCO
- SIC Code
- 3851
About Bausch + Lomb Corporation (BLCO) Stock
Bausch + Lomb Corporation (BLCO) closed the 2026-09-16 session at $17.07, down 0.93% versus the previous close (-0.16). The stock opened at $17.22 and traded between $17.01 and $17.34 during that session. Session trading volume was 194K shares. The volume-weighted average price (VWAP) is $17.12.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Bausch + Lomb Corporation has a market capitalization of $6.15 billion. The company operates in the OPHTHALMIC GOODS industry classification. BLCO is listed on the XNYS exchange. The company employs approximately 13,000 people. Bausch + Lomb Corporation is headquartered in VAUGHAN, A6. The recorded listing date is 2022-05-06.
On this page you can find market BLCO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the OPHTHALMIC GOODS sector.